Wilam Partners


CAI (Commissioning Agents International) are involved with commissioning and projects in the pharmaceutical, medical device, life sciences, building commissioning and data centre industries. We have recently launched a local presence in Australia and are bringing our experience to support the Australian Biotech, Pharma and Med device market. We also collaborate to develop the ISPE and Baseline Guides that the industry follows with employees of CAI on the document panels for these publications.
Since CAI was founded in 1996, we have delivered nearly a billion dollars in services for hundreds of clients across thousands of projects globally. With offices in the US, Canada, the United Kingdom, Netherlands, Korea, Switzerland, India, Ireland, Italy, China, Singapore, and now Australia, we are an international team of over 850+ professionals providing local support from a global company.
We help our customers design, deliver, operate, and maintain quality-critical manufacturing (GMP related) facilities. Our engineering, technical and consulting services encompass all aspects of operation: equipment, automation, process, human performance. The result is a superior level of operational performance and reliability.


CSIRO's vision is to create a better future for Australia by solving the greatest challenges through innovative science and technology.
We work with biomedical companies to deliver new medical treatments and technologies that benefit millions of people in Australia and overseas, helping them live longer, healthier and more productive lives.
CSIRO is one of the largest multidisciplinary science organisations in the world with over 6000 staff working in state-of-the-art facilities across Australia. Our research and development supports local businesses and the broader research community across preclinical, biomedical manufacturing, devices and sensors, diagnostics, eHealth and clinical trials. 


IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. 
IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries.


Moderna’s Mission is to deliver the greatest possible impact to people through mRNA medicines. The company was founded in 2010 and focused on building the leading mRNA technology platform, infrastructure to accelerate drug discovery and early development, a rapidly expanding pipeline, and a world-class team. When the world was disrupted by a global pandemic, mRNA technology played a critical role in protecting and restoring human health. With 48 mRNA programs in our pipeline spanning several therapeutic areas and rapidly progressing towards the clinic, we believe we are at the beginning of changing medicine forever.